Detalles de la búsqueda
1.
In vitro activity, pharmacodynamic profile and dose optimization of biapenem against NDM and OXA-48-like carbapenemase-producing Klebsiella pneumoniae: A multicentre study in Thailand.
J Glob Antimicrob Resist
; 37: 219-224, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552877
2.
The Activities of Antimicrobials Against Stenotrophomonas maltophilia Isolates and Evaluation of Clinical Outcomes Among Treatment Regimens in Patients with Stenotrophomonas maltophilia Infections: A Retrospective Multicenter Cohort Study.
Infect Drug Resist
; 16: 5173-5184, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37581163
3.
Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant Pseudomonas aeruginosa.
Antibiotics (Basel)
; 11(4)2022 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35453269
4.
The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant Klebsiella pneumoniae Clinical Isolates Harboring Different Carbapenemase Types in a Thai University Hospital.
Drug Des Devel Ther
; 15: 3095-3104, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34295150
5.
Antimicrobials as Single and Combination Therapy for Colistin-Resistant Pseudomonas aeruginosa at a University Hospital in Thailand.
Antibiotics (Basel)
; 9(8)2020 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32756327
Resultados
1 -
5
de 5
1
Próxima >
>>